Premium
Renal impairment is frequent in chronic hepatitis C patients under triple therapy with telaprevir or boceprevir
Author(s) -
LoustaudRatti Véronique,
Carrier Paul,
Vong Chanlina,
Essig Marie
Publication year - 2014
Publication title -
hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.488
H-Index - 361
eISSN - 1527-3350
pISSN - 0270-9139
DOI - 10.1002/hep.26730
Subject(s) - telaprevir , dolutegravir , raltegravir , medicine , boceprevir , ribavirin , renal function , pharmacology , gastroenterology , sofosbuvir , oncology , hepatitis c virus , virology , viral load , human immunodeficiency virus (hiv) , antiretroviral therapy , virus
International audienc
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom